Regulus Therapeutics Inc. (NASDAQ:RGLS) announced that it has commenced an underwritten public offering, subject to market and other conditions, to issue and sell approximately $80,000,000 of shares of its common stock, of which approximately $70,000,000 of shares are being offered by Regulus and approximately $10,000,000 of shares are being offered by an existing stockholder of Regulus, Isis Pharmaceuticals, Inc. Regulus Therapeutics Inc. (NASDAQ:RGLS) belongs to … Continue reading Stock Runners : Regulus Therapeutics Inc. (NASDAQ:RGLS), American Airlines Group Inc. (NASDAQ:AAL), H&R Block, Inc. (NYSE:HRB), Allergan Inc. (NYSE:AGN), Marine Products (NYSE:MPX)